skip to main content

Dr. Victor Ling, PHD, O.C., O.B.C.

Founding President and Scientific Director

Dr. Victor Ling is the founding president and scientific director of TFRI. He is an authority on multi-drug resistance in cancer and is well-known for his discovery of P-glycoprotein, the first molecule identified to be responsible for drug resistance. Dr. Ling was the vice-president of discovery research at the BC Cancer Agency. Dr. Ling provides overall leadership to TFRI, the development of translational research, relationships with stakeholders, and TFRI communications.